Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The study was devoted to the comparison of the probiotic effect of enterococcal Enterococcus faecium L3 to the antibiotic enramycin as a chicken feed additive. Two hundred and sixteen chickens were divided into three groups and tested by different parameters including weight gain, food consumption, blood biochemistry, immunology, and caecal microbiome at two checkpoints, 21 and 39 days after birth. By the end of the experiment, a group of chickens getting probiotic demonstrated weight gain of more than 100 g at the average relative to the control group with no additive in animal feed (P < 0.05). Blood serum biochemistry showed a significant increase in HDL level (P < 0.05) relative to the control group. The 16S RNA sequencing demonstrated the growth abundance of Lachnospiraceae and the decrease of Proteobacteria in probiotic fed group. On the contrary, the antibiotic fed group showed a noticeable increase in the abundance of Proteobacteria which included the genus Salmonella. Thus, probiotic E. faecium L3 being added to chicken food as a single additive may be considered as a possible replacement of antibiotic enramycin.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12602-022-09970-0DOI Listing

Publication Analysis

Top Keywords

enterococcus faecium
8
weight gain
8
evaluation efficacy
4
efficacy enterococcus
4
faecium feed
4
feed probiotic
4
probiotic additive
4
additive chicken
4
chicken study
4
study devoted
4

Similar Publications

Reprogramming resistance: phage-antibiotic synergy targets efflux systems in ESKAPEE pathogens.

mBio

September 2025

Flinders Accelerator for Microbiome Exploration, College of Science and Engineering, Flinders University, Adelaide, South Australia, Australia.

Multidrug-resistant (MDR) and extensively drug-resistant (XDR) ESKAPE pathogens pose a significant global health threat due to their ability to evade antibiotics through intrinsic and acquired mechanisms. These bacteria, including , , , , , and species, evade antibiotics through intrinsic and adaptive mechanisms. Common strategies include capsule formation, biofilm, β-lactamase production, and efflux activity.

View Article and Find Full Text PDF

The coexistence of pharmaceuticals and microorganisms in source separated urine poses a risk for the development of antimicrobial resistance (AMR), especially when urine-based fertilizers are applied to soils. While prior studies have investigated pathogen inactivation in source-separated wastewater matrices, few have evaluated the simultaneous fate of antibiotic-resistant bacteria (ARBs) and their corresponding resistance genes (ARGs) in real urine matrices, particularly under alkaline conditions. Here, we studied the inactivation of β-lactamase-producing and vancomycin-resistant and the degradation of their respective ARGs ( and A) in alkalized, unhydrolyzed urine (pH 10.

View Article and Find Full Text PDF

Listeria monocytogenes poses a serious food safety risk due to its ability to survive and grow on produce during cold storage. This study evaluates Enterococcus faecium NRRL B-2354 as a non-pathogenic surrogate for L. monocytogenes during up to 24 weeks of simulated lab storage and 36 weeks of commercial storage, including refrigerated air (RA), controlled atmosphere (CA), CA with 1-methylcyclopropene (1-MCP), with or without gaseous ozone treatment.

View Article and Find Full Text PDF

Objectives: Vancomycin-resistant enterococcal bloodstream infections (VRE-BSIs) carry high mortality in patients with malignancy. While neutropenia is a known risk factor for mortality in patients with malignancy and BSI, its impact on the effectiveness of daptomycin and linezolid in VRE-BSI is not well defined.

Methods: We conducted a multicenter cohort study of hospitalized patients aged ≥18 years with malignancy and VRE-BSI between 2010 and 2021.

View Article and Find Full Text PDF

Novel Enterococcus phage BUCT630: Isolation and genomic insights targeting drug-resistant Enterococcus faecium in vitro and in vivo.

Microb Pathog

September 2025

College of Life Sciences and Technology, Beijing University of Chemical Technology, Beijing, 100029, China; Beijing Advanced Innovation Center for Soft Matter Science and Engineering, Beijing University of Chemical Technology, Beijing, 100029, China. Electronic address:

The antibiotic-resistant Enterococcus faecium (E. faecium) is a significant health issue requiring alternative therapies. Phages could be an alternative to antibiotics and have promising activity in both in vitro and in vivo experiments.

View Article and Find Full Text PDF